Drug intelligence / Profile preview

ucb mononuclear cells + uc-msc exosomes

Development stage
Unknown
Lead developer
Anhui Provincial Tumor Hospital
Modality
Cell Therapies, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

UCB mononuclear cells + UC-MSC exosomes is a combination biologic therapy being investigated for the treatment of radiation pneumonitis. The therapy consists of mononuclear cells derived from umbilical cord blood (UCB-MNCs) and exosomes harvested from umbilical cord-derived mesenchymal stem cells (UC-MSC-Exos). UCB-MNCs provide a diverse population of progenitor and immune cells that may contribute to tissue repair, while UC-MSC exosomes act as paracrine mediators, delivering a cargo of anti-inflammatory proteins and microRNAs to the site of injury. This dual approach aims to mitigate the inflammatory cascade and fibrotic changes associated with radiation-induced lung damage, potentially improving clinical outcomes for cancer patients undergoing thoracic radiotherapy.

Other names
UCB mononuclear cells + UC-MSC exosomesumbilical cord blood mononuclear cells combined with umbilical cord mesenchymal stem cell-derived exosomes

Beyond the preview

Go deeper on ucb mononuclear cells + uc-msc exosomes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ucb mononuclear cells + uc-msc exosomes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call